Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Early research (Phase 1)Looking for participantsNCT07517198
What this trial is testing

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Who this might be right for
Solid TumorSmall Cell Lung Cancer (SCLC)High Grade Neuroendocrine Cancer+9 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT01433263
What this trial is testing

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Who this might be right for
Cachexia
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT00940069
What this trial is testing

TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer

Who this might be right for
Non-small-cell Lung CancerAdenocarcinoma
Hunan Province Tumor Hospital 60
Not applicableEnded earlyNCT01071434
What this trial is testing

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Who this might be right for
Pancreatic CancerLiver CancerLung Cancer+7 more
Stanford University 5
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT03704870
What this trial is testing

Outcomes Following Omission of Daily Routine Chest Radiographs Following Pulmonary Resection

Who this might be right for
Lung CancerLung DiseasesLung Cancer, Nonsmall Cell+2 more
University Health Network, Toronto 50
Large-scale testing (Phase 3)Ended earlyNCT00113386
What this trial is testing

Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 19
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Not applicableLooking for participantsNCT05550961
What this trial is testing

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

Who this might be right for
NSCLCCancerLung Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 1,200
Early research (Phase 1)Study completedNCT03681483
What this trial is testing

RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00003587
What this trial is testing

S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 204
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Large-scale testing (Phase 3)Study completedNCT00002823
What this trial is testing

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 3,300
Testing effectiveness (Phase 2)Ended earlyNCT02117024
What this trial is testing

Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Heat Biologics 66
Large-scale testing (Phase 3)Ended earlyNCT00004859
What this trial is testing

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI) 589
Not applicableUnknownNCT01100827
What this trial is testing

A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status

Who this might be right for
NSCLC
National University Hospital, Singapore
Early research (Phase 1)Looking for participantsNCT07284186
What this trial is testing

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastric Squamous Cell Carcinoma+7 more
Plexium, Inc. 155
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Large-scale testing (Phase 3)WithdrawnNCT00054392
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Next Page